Ausgabe 1/2015
Inhalt (24 Artikel)
Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease
Wen-Ying Wang, Jin-Tai Yu, Yong Liu, Rui-Hua Yin, Hui-Fu Wang, Jun Wang, Lin Tan, Joaquim Radua, Lan Tan
Mini review: linkage between α-Synuclein protein and cognition
Huda Saleh, Ayeh Saleh, Hailan Yao, Jie Cui, Yong Shen, Rena Li
Direct reprogramming of induced neural progenitors: a new promising strategy for AD treatment
Siqiang Lai, Min Zhang, Dongsheng Xu, Yiying Zhang, Lisha Qiu, Changhai Tian, Jialin Charlie Zheng
The promise of stem cells in the therapy of Alzheimer’s disease
Chunmei Yue, Naihe Jing
Posttranslational modifications of α-tubulin in alzheimer disease
Fan Zhang, Bo Su, Chunyu Wang, Sandra L. Siedlak, Siddhartha Mondragon-Rodriguez, Hyoung-gon Lee, Xinglong Wang, George Perry, Xiongwei Zhu
Acid-sensing ion channels: potential therapeutic targets for neurologic diseases
Sha Liu, Xiao-Yu Cheng, Fen Wang, Chun-Feng Liu
Wnt3a protects SH-SY5Y cells against 6-hydroxydopamine toxicity by restoration of mitochondria function
Lei Wei, Li Ding, Ming-shu Mo, Ming Lei, Limin Zhang, Kang Chen, Pingyi Xu
Update on deep brain stimulation in Parkinson’s disease
Daniel Martinez-Ramirez, Wei Hu, Alberto R. Bona, Michael S. Okun, Aparna Wagle Shukla
Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis
Satoshi Yamashita, Yukio Ando
Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis
Zhen Jiang, Wenzhang Wang, George Perry, Xiongwei Zhu, Xinglong Wang
Clinical management and associated costs for moderate and severe Alzheimer’s disease in urban China: a Delphi panel study
Xin Yu, Shengdi Chen, Xiaochun Chen, Jianjun Jia, Chunhou Li, Cong Liu, Mondher Toumi, Dominique Milea
Development of stem cell-based therapy for Parkinson’s disease
Fabin Han, Deborah Baremberg, Junyu Gao, Jing Duan, Xianjie Lu, Nan Zhang, Qingfa Chen
New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis
Xueping Chen, Hui-Fang Shang
The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration
Yong-Bo Hu, Eric B Dammer, Ru-Jing Ren, Gang Wang
Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
Qinqin Wang, Yingjun Liu, Jiawei Zhou
The associations between Parkinson’s disease and cancer: the plot thickens
Danielle D. Feng, Waijiao Cai, Xiqun Chen
The association between Parkinson’s disease and melanoma: a systematic review and meta-analysis
Pei Huang, Xiao-Dong Yang, Sheng-Di Chen, Qin Xiao
Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases
Zhen Ni, Robert Chen
No apparent transmission of transgenic α–synuclein into nigrostriatal dopaminergic neurons in multiple mouse models
Namratha Sastry, Wang Zheng, Guoxiang Liu, Helen Wang, Xi Chen, Michael Cai, Parth Contractor, Carmelo Sgobio, Lixin Sun, Chengsong Xie, Huaibin Cai
Pilot study of atomoxetine in patients with Parkinson’s disease and dopa-unresponsive Freezing of Gait
Gonzalo J. Revuelta, Aaron Embry, Jordan J. Elm, Chris Gregory, Amy Delambo, Steve Kautz, Vanessa K. Hinson
Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis
Honglei Chen, Edward J Zhao, Wen Zhang, Yi Lu, Rui Liu, Xuemei Huang, Anna J Ciesielski-Jones, Michele A Justice, Deborah S Cousins, Shyamal Peddada
Characteristics of language impairment in Parkinson’s disease and its influencing factors
Lin Liu, Xiao-Guang Luo, Chui-Liang Dy, Yan Ren, Yu Feng, Hong-Mei Yu, Hong Shang, Zhi-Yi He
Treatment of the later stages of Parkinson’s disease – pharmacological approaches now and in the future
Peter Jenner
How to optimize the treatment of early stage Parkinson’s disease
Fabrizio Stocchi, Laura Vacca, Fabiana G Radicati